All In Biotech

Drug Trial Radar · NCT06872892

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY™ Study)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,755 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,755

Planned (sponsor's estimate)

Start

Jun 9, 2025

Primary completion

Jun 15, 2027

Study completion Dec 20, 2027

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Mar 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find out whether a medicine called BI 1291583 helps people with bronchiectasis. Participants are put into 2 groups randomly, which means by chance. One group takes BI 1291583 tablets and the other group takes placebo tablets. A placebo tablet looks like the BI 1291583 tablet but does not contain any medicine. Participants take 1 tablet once a day for up to 1 year and 6 months. Participants are in the study for up to 1 year and 8 months. During this time, participants visit the study site up to 10 times and get about 13 phone calls from the site staff. Participants regularly complete a diary on a smartphone about their bronchiectasis symptoms and study doctors regularly check for any changes. The study doctors document when participants experience flare-ups. The number of flare-ups is compared between the participants who receive BI 1291583 and those who receive the placebo. The study doctors also regularly check participants' health and take note of any unwanted effects.

Conditions

  • Bronchiectasis

Interventions

  • BI 1291583Drug

    BI 1291583

  • Placebo matching BI 1291583Drug

    Placebo matching BI 1291583

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualised rate of adjudicated pulmonary exacerbations (number of events per person year) up to Week 76Time frame: up to 76 weeks

Locations

474 sites in 46 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • University of Arizona

    Tucson, Arizona · Active not recruiting

  • Newport Native MD, Inc

    Newport Beach, California · Active not recruiting

  • Paradigm Clinical Research - Redding

    Redding, California · Active not recruiting

  • University of California Davis

    Sacramento, California · Active not recruiting

  • University of California San Francisco

    San Francisco, California · Active not recruiting

  • Ventura County Medical Center

    Ventura, California · Completed

  • National Jewish Health

    Denver, Colorado · Active not recruiting

  • Yale University School of Medicine

    North Haven, Connecticut · Active not recruiting

  • Georgetown University

    Washington D.C., District of Columbia · Active not recruiting

  • Meris Clinical Research-Brandon-69466

    Brandon, Florida · Active not recruiting

  • St. Francis Medical Institute

    Clearwater, Florida · Completed

  • North Florida/South Georgia Veterans Health System

    Gainesville, Florida · Completed

  • University of Florida College of Medicine

    Jacksonville, Florida · Completed

  • Mayo Clinic - Florida

    Jacksonville, Florida · Active not recruiting

  • University of Miami

    Miami, Florida · Active not recruiting

  • Essence MD Research

    Naples, Florida · Active not recruiting

  • Vantage Clinical Trials - Tampa

    Tampa, Florida · Active not recruiting

  • Cleveland Clinic Florida

    Weston, Florida · Active not recruiting

  • Emory University

    Atlanta, Georgia · Completed

  • Augusta University

    Augusta, Georgia · Active not recruiting

  • Indiana University

    Indianapolis, Indiana · Completed

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa · Completed

  • University of Kansas Medical Center

    Kansas City, Kansas · Active not recruiting

  • Johns Hopkins Hospital

    Baltimore, Maryland · Completed

  • University of Maryland St. Joseph Medical Group Pulmonary Care and Sleep Medicine

    Towson, Maryland · Completed

  • Massachusetts General Hospital

    Boston, Massachusetts · Active not recruiting

  • UMASS Memorial Medical Center

    Worcester, Massachusetts · Active not recruiting

  • University of Michigan

    Ann Arbor, Michigan · Active not recruiting

  • Mayo Clinic, Rochester

    Rochester, Minnesota · Active not recruiting

  • HealthPartners Specialty Center 401 Building

    Saint Paul, Minnesota · Active not recruiting

  • University Of Mississippi Medical Center

    Jackson, Mississippi · Active not recruiting

  • The Lung Research Center, LLC

    Chesterfield, Missouri · Completed

  • Washington University School of Medicine

    St Louis, Missouri · Active not recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Completed

  • University of Nebraska Medical Center

    Omaha, Nebraska · Active not recruiting

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Completed

  • Rutgers Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Active not recruiting

  • New York Medical College - Hawthorne

    Hawthorne, New York · Active not recruiting

  • Northwell Health

    New Hyde Park, New York · Active not recruiting

Showing 40 of 474 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.